The store will not work correctly when cookies are disabled.
(E)-1-(3-(4-fluorophenyl)acryloyl)-3-(thiophene-2-carbonyl)imidazolidin-2-one
ID: ALA4743682
PubChem CID: 162646290
Max Phase: Preclinical
Molecular Formula: C17H13FN2O3S
Molecular Weight: 344.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/c1ccc(F)cc1)N1CCN(C(=O)c2cccs2)C1=O
Standard InChI: InChI=1S/C17H13FN2O3S/c18-13-6-3-12(4-7-13)5-8-15(21)19-9-10-20(17(19)23)16(22)14-2-1-11-24-14/h1-8,11H,9-10H2/b8-5+
Standard InChI Key: DDQDWNWUEDSNAF-VMPITWQZSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
8.3875 -26.4916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4861 -25.6582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4850 -26.4856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1997 -26.8985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9162 -26.4851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9133 -25.6546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1979 -25.2455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6262 -25.2395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3422 -25.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0551 -25.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7712 -25.6439 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0520 -24.4091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8629 -26.4633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6705 -26.6318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0803 -25.9158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5260 -25.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6946 -24.4972 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9005 -25.8263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2331 -25.0714 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7701 -26.8975 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.1399 -27.2780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8087 -27.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4740 -27.2732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2163 -26.4901 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
6 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 11 1 0
16 17 2 0
15 18 1 0
18 1 1 0
18 19 2 0
3 20 1 0
1 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 1 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.37 | Molecular Weight (Monoisotopic): 344.0631 | AlogP: 3.01 | #Rotatable Bonds: 3 |
Polar Surface Area: 57.69 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.16 | CX LogD: 3.16 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.80 | Np Likeness Score: -1.36 |
References
1. Ji L,Qu L,Wang C,Peng W,Li S,Yang H,Luo H,Yin F,Lu D,Liu X,Kong L,Wang X. (2021) Identification and optimization of piperlongumine analogues as potential antioxidant and anti-inflammatory agents via activation of Nrf2., 210 [PMID:33148493] [10.1016/j.ejmech.2020.112965] |